[PDF] Top 20 Práctica 3 Propiedades Químicas de Aldehidos y Cetonas
Has 10000 "Práctica 3 Propiedades Químicas de Aldehidos y Cetonas" found on our website. Below are the top 20 most common "Práctica 3 Propiedades Químicas de Aldehidos y Cetonas".
Patient engagement and self-management in pulmonary arterial hypertension
... This includes the emotional impact of PAH, treatment options and the implications of different modes of drug administration [5]. Patients have highlighted a lack of sufficient information exchange between expert PAH ... See full document
134
Optimal management of severe pulmonary arterial hypertension
... of Pulmonary Hypertension were found to present at a younger age with particularly severe haemodynamic impairment, despite being predominantly in NYHA/WHO FC III, and to show significantly shorter time to ... See full document
7
Early detection and management of pulmonary arterial hypertension
... in Pulmonary Arterial Hypertension)-2, the uncontrolled, open-label extension trial of SUPER-1, demonstrated that the majority of patients (60%) who entered SUPER-1 improved or maintained their ... See full document
11
The changing landscape of pulmonary arterial hypertension and implications for patient care
... with pulmonary arterial hypertension (PAH) since the ...and management of the disease, as well as the need for earlier and improved diagnosis in these ... See full document
83
Update on pulmonary arterial hypertension in children: management strategies and clinical utility of sildenafil
... objective patient characteristics should also be considered, especially in pediatrics, as the regimen can require high levels of compliance and cause significant adverse ... See full document
6
Integrated care and optimal management of pulmonary arterial hypertension
... Abstract: Pulmonary arterial hypertension (PAH) may occur as an idiopathic process or as a component of a variety of diseases, including connective tissue diseases, congenital heart disease, and ... See full document
8
Connective tissue disease associated with pulmonary arterial hypertension: management of a patient with severe haemodynamic impairment
... The patient was referred to the national pulmonary hypertension reference centre (Centre de Re´fe´rence de l’hypertension pulmonaire se´ve`re, Hoˆpital Biceˆtre, Universite´ Paris-Sud, Le ... See full document
41
Safety and tolerability of bosentan in the management of pulmonary arterial hypertension
... In our experience, the selection of therapy must take into consideration an individual’s disease severity, rapidity of progression and signs of poor prognosis. For patients in NYHA Classes II and III, monotherapy with ... See full document
5
The spectrum of pulmonary arterial hypertension in adults with congenital heart disease: management from a physician and nurse specialist perspective
... the patient and requires strategic planning to accommodate into a patient’s ...line management and drug reconstitution, as well as managing and troubleshooting the infusion ...the patient on how the ... See full document
6
Prostanoid therapies in the management of pulmonary arterial hypertension
... Associated with deficiencies in production or action, pros- tacyclin has been identified as having an important role in the pathobiology of PAH. The treatment of PAH patients with epoprostenol and related molecules takes ... See full document
5
Management of severe pulmonary arterial hypertension
... this patient group are lacking, and there is an obvious need for studies that address the specific issues associated with such a severely ill ...improving management and outcome, with decreased emphasis on ... See full document
5
Pulmonary hypertension
... FK506 (tacrolimus) can act as a potent BMPR2 activator that reverses experimental PAH. Based on these findings, the same group recently reported the outcome of the first three patients treated with FK506 [51]. Further ... See full document
67
Healthcare utilization, medical expenditure, and mortality in Korean patients with pulmonary hypertension
... All-cause mortality during follow-up was assessed until January 2017. For the confirmation of death, we used the database from the Korean Ministry of Security and Public Administration. Healthcare utilization and med- ... See full document
5
Pulmonary Hypertension Induced by Thalidomide (and Derivatives) in Patients with Multiple Myeloma: A Systematic Review
... the patient presented to the center with dizziness, as- thenia, and ...whether pulmonary hypertension is considered as an ad- verse effect of thalidomide and how the drug eventually affects the ... See full document
88
The improvement of pulmonary artery pressure after bosentan therapy in patients with β-thalassemia and Doppler-defined pulmonary arterial hypertension
... each patient, including blood transfusion history, iron-chelating medications, T2-weighted magnetic resonance imaging (MRI T2*) of the heart, and concurrent and historical drugs related to the treatment of ... See full document
31
Pulmonary hypertension secondary to hyperviscosity in a patient with rheumatoid arthritis and acquired von Willebrand disease: a case report
... The patient was admitted to the ER in April 2011 with a 24-hour evolution of progressive dyspnea, cough, thoracic pain, and palpitations, 104beats/minute, 60/ 40mmHg, temperature of 38°C, pulse oximetric satur- ... See full document
12
Platelet derived growth factor receptor β and epidermal growth factor receptor in pulmonary vasculature of systemic sclerosis associated pulmonary arterial hypertension versus idiopathic pulmonary arterial hypertension and pulmonary veno occlusive disease: a case control study
... small pulmonary arteries and plexiform lesions [33]. In pulmonary capillary haemangiomatosis, an entity that shows overlap with both PVOD [42] and SScPAH [19], up-regulation of PDGF-B and PDGFR-ß genes has ... See full document
11
Bosentan in the treatment of pulmonary arterial hypertension with the focus on the mildly symptomatic patient
... Abstract: Pulmonary arterial hypertension (PAH) is a progressive disease with poor survival ...in pulmonary vascular resistance is merely a surrogate marker for the intended aim of delaying ... See full document
7
Pregnancy in pulmonary arterial hypertension
... in pulmonary artery pressure in PAH patients [39, 40]. Further management of women with PAH following delivery includes advice with regards to ...as pulmonary vasodilators may be excreted in breast ... See full document
163
The arterial load in pulmonary hypertension
... basic arterial properties and, thus, occurs in both the pulmonary and systemic arterial ...the pulmonary arterial ...common pulmonary artery and proximal left and right arteries ... See full document
23
Related subjects